PICOSALAX - Medsafe
- 1 - PICOSALAX - PICOSAL004 12 January2015 PICOSALAX Sodium picosulfate 10.0mg, magnesium oxide 3.5g, citric acid 12.0g Presentation White crystalline powder.
Download PICOSALAX - Medsafe
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Liquid oxygen - Air Products & Chemicals
www.airproducts.comOxygen is the second largest component of the atmosphere, comprising 20.8% by volume. Liquid oxygen is pale blue and extremely cold. Although nonflammable, oxygen is a strong oxidizer.
Product, Chemical, Liquid, Air products amp chemicals, Oxygen, Liquid oxygen
Liquid nitrogen - Air Products & Chemicals
www.airproducts.comLiquid nitrogen is inert, colorless, odorless, noncorrosive, nonflammable, and extremely cold. Nitrogen makes up the major portion of the atmosphere (78.03% by volume, 75.5% by weight).
Product, Chemical, Liquid, Nitrogen, Liquid nitrogen, Air products amp chemicals
Product Bulletin: LR125 Pressure Reducing Liquid Regulator
www.emerson.comBulletin 71.2LR125 4 Easy-to-Maintain—The pilot is designed to allow quick and simple in-line trim inspection and parts replacement. Powder Paint Coating—Carbon steel body is powder paint coated providing superior impact, abrasion and
Liquid, Pressure, Reducing, Powder, Regulators, Lr125, Lr125 pressure reducing liquid regulator
SCHEDULING STATUS: S3 PROPRIETARY NAME (and dosage …
www.epilepsy.org.za3 presence of co-medication. The percentage of free (unbound) drug is usually between 6 % and 15 % of total plasma levels. The pharmacological (or therapeutic) effects of Epilim are not clearly correlated with the total or free (unbound) plasma valproic acid levels.
Name, Scheduling, Status, Proprietary, Scheduling status, S3 proprietary name
NEW ZEALAND DATA SHEET Herceptin (trastuzumab)
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Herceptin (trastuzumab) Herceptin 180501 1 1. PRODUCT NAME Herceptin 150 mg powder for concentrate for solution for infusion
Vital Greens Info Sheet - Naka Herbs & Vitamins
www.nakaherbs.comVital Greens is a liquid scientifically formulated to provide faster and absorption! superior Other leading green products are powder-based. In-vitro
BOMANITE LIQUID RELEASE ADVANTAGE
www.texasbomanite.com8789 Auburn Folsom Rd. #108, Granite Bay, CA 95746 i (303) 369-1115 i FAX: (303) 291-0282 Web site: www.bomanite.com i E-mail: info@bomanite.comi June 2009 BOMANITE LIQUID RELEASE ADVANTAGE Technical Bulletin and Application Guideline
Liquid, Release, Advantage, Bomanite liquid release advantage, Bomanite